Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Multi-center, Phase 3 Trial to Evaluate the Efficacy and Safety of a Fixed Dose Combination of Telmisartan and S-Amlodipine(TELMINUVO TAB.) Versus S-Amlodipine Monotherapy in Patients With Stage 2 Hypertension
Conditions
Interventions
TELMINUVO Tab. (80/2.5mg)
TELMINUVO Tab. (80/5mg)
+2 more
Locations
1
South Korea
The catholic university of Korea Seoul St. Mary's hospital
Seoul, South Korea
Start Date
January 1, 2014
Primary Completion Date
August 1, 2014
Completion Date
August 1, 2014
Last Updated
November 14, 2013
NCT02417740
NCT07073820
NCT07480265
NCT06876233
NCT06062394
NCT06899815
Lead Sponsor
Chong Kun Dang Pharmaceutical
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions